Top Stories

The PE firm recently merged three brands to form Red Apple Cheese and will be spending another $50m for add-ons.

This past year has seen a boost in grants as the global pandemic and social justice issues increased the need for donations in society, according to Jason Wright of Apax.

The PE firm owned the tax credit company for almost a decade.

Apollo's multi-product therapeutic portfolio is a healthcare model Patient Square execs like and know well, with founder Jim Momtazee having invested behind likeminded playbooks at Jazz Pharmaceuticals and BridgBio during his days at KKR.

Top candidates consistently have at least two offers in front of them – and the competition is even fiercer for diverse candidates, Heidrick and Struggles's Jonathan Goldstein tells PE Hub.

Berkshire Partners' Affordable Care scores a valuation of some $2.7bn as technology adoption, future M&A opportunities and a large and growing tooth replacement market present a favorable backdrop for the specialist DSO.

Grattan brings vast software investing experience from THL, where she was involved with deals including Nextech, Alfresco Software, iHeartMedia, Juvare, inVentiv Health, Univision Communications, and West Corporation.

Accelmed looks to stand out by investing in US-based HealthTech companies that are unlikely to appeal to the traditional private equity fund, taking advantage of its Israel-based team that sources add-ons.

The data integrity software company earlier this month bought data governance software provider Infogix.

The acquisition of the Puerto Rico healthcare organization adds to GlobalHealth, an Oklahoma-based HMO that Kinderhook backed in 2014.